About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Il23rtm1.1Ngh
targeted mutation 1.1, Nico Ghilardi
MGI:5619109
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Il23rtm1.1Ngh/Il23rtm1.1Ngh involves: C57BL/6 MGI:5692285
cx2
Il23rtm1.1Ngh/Il23rtm1.1Ngh
Rag2tm1Fwa/Rag2tm1Fwa
involves: 129S/SvEv * C57BL/6 MGI:5693391


Genotype
MGI:5692285
hm1
Allelic
Composition
Il23rtm1.1Ngh/Il23rtm1.1Ngh
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il23rtm1.1Ngh mutation (0 available); any Il23r mutation (68 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• low levels of IL22 after DSS treatment
• increase in levels after DSS treatment is less than for controls
• significantly less weight loss after treatment with Sodium Dextran Sulfate (DSS) than in controls

immune system
• less colon shortening
• decreased leukocyte infiltration
• less crypt loss
• reduced epithelial hyperplasia
• low levels of IL22 after DSS treatment
• increase in levels after DSS treatment is less than for controls

digestive/alimentary system
• less colon shortening
• decreased leukocyte infiltration
• less crypt loss
• reduced epithelial hyperplasia




Genotype
MGI:5693391
cx2
Allelic
Composition
Il23rtm1.1Ngh/Il23rtm1.1Ngh
Rag2tm1Fwa/Rag2tm1Fwa
Genetic
Background
involves: 129S/SvEv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il23rtm1.1Ngh mutation (0 available); any Il23r mutation (68 available)
Rag2tm1Fwa mutation (48 available); any Rag2 mutation (119 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• 15% weight loss after treatment with 2.5% Sodium Dextran Sulfate (DSS) for 5 days
• fail to recover until 10 days after treatment
• IL22 treatment protects against weight loss

digestive/alimentary system
• increased crypt loss and epithelial damage after treatment with 2.5% DSS for 5 days
• IL22 treatment protects against crypt loss
• short colon after treatment with 2.5% DSS for 5 days
• IL22 treatment protects against colon shortening

immune system
• reduced expression of IL22 after DSS treatment
• reduced expression after DSS treatment

homeostasis/metabolism
• reduced expression of IL22 after DSS treatment

endocrine/exocrine glands
• increased crypt loss and epithelial damage after treatment with 2.5% DSS for 5 days
• IL22 treatment protects against crypt loss





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
07/05/2024
MGI 6.24
The Jackson Laboratory